Paul Hastings advised Viking Therapeutics on the offering. Viking Therapeutics, Inc. (Nasdaq: VKTX) executed its underwritten offering of $632.5 million of shares of its common stock....
Viking Therapeutics’ $632.5 Million Common Stock Offering
Salt Mobile’s €150 Million Term Loan Facility
Paul Hastings LLP advised Goldman Sachs International and BNP as lenders in the transaction. Matterhorn Telecom S.A., the parent company of Salt Mobile S.A., announced the...
Petroleos de Venezuela S.A. v. MUFG Union Bank, N.A.
Paul Hastings LLP earned a victory in the New York Court of Appeals on behalf of the Ad Hoc Board of Petroleos de Venezuela (PDVSA), Venezuela’s...
Humacyte’s $40 Million Public Offering
Covington & Burling represented Humacyte, while Paul Hastings advised TD Cowen, Cantor and BTIG in the offering. Humacyte, Inc. executed an underwritten public offering of 13,400,000 shares...
Kiloutou’s €650 Million High-Yield Refinancing
Paul Hastings LLP advised Kiloutou on the issuance. Kiloutou, a leading generalist equipment rental company in Europe and portfolio company of HLD and Dentressangle, announced the issuance...
Hyundai Capital Services, Inc.’s $1 Billion Global Bond Sale
Paul Hastings LLP acted for the joint lead managers. Hyundai Capital Services Inc., South Korea’s leading auto finance company, closed a dual-tranche issuance of US$500,000,000 5.125%...
Jasper Therapeutics’ $50 Million Common Stock Offering
Paul Hastings LLP advised Jasper Therapeutics, Inc., while DLA Piper advised the underwriters. Jasper Therapeutics, Inc. (Nasdaq: JSPR), a clinical-stage biotechnology company focused on developing novel...
Javelin Global Commodities’ Partnership with Minera BMR SpA
Paul Hastings LLP advised Javelin Global Commodities in connection with its entry into multiple agreements with Battery Mineral Resources Corp.’s Chilean subsidiary, Minera BMR SpA. Battery...
Spearmint Energy’s $47.5 Million Financing for Battery Energy Storage Project in ERCOT
Javelin Capital supported Spearmint as financial advisor on the transaction and Paul Hastings LLP served as legal counsel to Spearmint. Manulife was supported on the transaction...
Zededa, Inc.’s $72 Million Growth Financing Round
Paul Hastings LLP advised Zededa, Inc. in connection with the round. Zededa, the leader in edge management and orchestration, announced the closing of $72 million in...
Wood Mackenzie’s $1.465 Billion Refinancing
Paul Hastings LLP advised Bank of America and the other joint lead arrangers. Wood Mackenzie announced its $1.465 billion refinancing of its credit facilities. Wood Mackenzie empowers...
PepGen’s $80.1 Million Offering
Paul Hastings LLP advised Leerink Partners on the matter. PepGen Inc. (Nasdaq: PEPG), a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the...